- Expires: December 28, 2022
- Credit: 1.00hr(s)
- CME
- Therapeutic Areas: Oncology, Urologic oncology
- Specialties: urothelial carcinoma (UC)
- On-Demand
Upstream and Downstream Targeting of the Complement Pathway to Manage PNH: Current and Emerging Inhibitors
- Available: December 31, 2021 —
- December 30, 2022
- Credit: 0.50hr(s)
- Credit Types: CME
- Therapeutic Areas: Hematology, Benign, Oncology
- Location: Internet Activity Enduring
Course Description
In this activity, an expert in hematology-oncology provides an overview of paroxysmal nocturnal hemoglobinuria (PNH) and discusses current and emerging treatment options for managing PNH.
Other Courses in this Series
Other Courses That May be of Interest
- Series: CLL/SLL
- Expires: December 14, 2023
- Credit: 0.30hr(s)
- AAPA, CME, CPE, NCPD
- Therapeutic Areas: Hematologic Oncology, Oncology
- Specialties: Chronic Lymphocytic Leukemia (CLL), Small lymphocytic lymphoma (SLL)
- Series: NSCLC
- Expires: November 28, 2023
- Credit: 0.30hr(s)
- NCPD
- Therapeutic Areas: Hematologic Oncology, Oncology
- Specialties: Biomarkers, NSCLC
- Series: CLL/SLL
- Expires: December 14, 2023
- Credit: 0.30hr(s)
- AAPA, CME, CPE, NCPD
- Therapeutic Areas: Hematologic Oncology, Oncology
- Specialties: Chronic Lymphocytic Leukemia (CLL), Small lymphocytic lymphoma (SLL)
- Series: NSCLC
- Expires: November 28, 2023
- Credit: 0.15hr(s)
- NCPD
- Therapeutic Areas: Hematologic Oncology, Oncology
- Specialties: Biomarkers, NSCLC
- Series: CLL/SLL
- Expires: December 14, 2023
- Credit: 0.30hr(s)
- AAPA, CME, CPE, NCPD
- Therapeutic Areas: Hematologic Oncology, Oncology
- Specialties: Chronic Lymphocytic Leukemia (CLL), Small lymphocytic lymphoma (SLL)
- Series: NSCLC
- Expires: November 28, 2023
- Credit: 0.15hr(s)
- NCPD
- Therapeutic Areas: Hematologic Oncology, Oncology
- Specialties: Biomarkers, NSCLC
- Series: NSCLC
- Expires: November 28, 2023
- Credit: 0.30hr(s)
- NCPD
- Therapeutic Areas: Hematologic Oncology, Oncology
- Specialties: Biomarkers, NSCLC